Platelet function and cardiopulmonary bypass

Seminars in Cardiothoracic and Vascular Anesthesia

Volumn 5, Issue 4, 2001, Pages 273-281

  Samson, S ^a   Shore Lesserson, L ^a  

^a Box 1010 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING; CARDIOPULMONARY BYPASS; EXTRACORPOREAL CIRCULATION; FIBRINOLYSIS; HEART SURGERY; HEMOSTASIS; POSTOPERATIVE HEMORRHAGE; REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION;

EID: 0035679795     PISSN: 10892532     EISSN: None     Source Type: Journal    
DOI: 10.1053/scva.2001.28174     Document Type: Review

References (62)

1. The pathogenesis and control of the hemorrhagic defect in openheart surgery
2. Coagulation defects and bleeding in open heart surgery
3. Alterations in fibrinolysis and coagulation associated with cardiopulmonary bypass
4. Hemostasis defects associated with cardiac surgery, prosthetic devices, and other extracorporeal circuits
5. Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro
6. Effect of skin temperature on platelet function in patients undergoing extracorporeal bypass
7. Platelet function in cardiac surgery: Influence of temperature and aprotinin
8. Effect of heparin on fibrinolytic activity, and platelet function in vivo
9. The effect of protamine sulfate on platelet function
10. The effects of heparinase I and protamine on platelet reactivity
11. Plasmin inhibition of platelet function and of arachidonic acid metabolism
12. Temperature dependence of plasmin-induced activation or inhibition of human platelets
13. Modulation of platelet surface adhesion receptors during cardiopulmonary bypass
14. The platelet thrombin receptor and postoperative bleeding
15. Aprotinin inhibits plasmin induced platelet activation during cardiopulmonal T bypass
16. Platelet-rich plasma sequestration, with therapeutic platelet yields, reduces alIogeneic transfusion in complex cardiac surgery
17. The effect of transfusion of fresh whole blood versus platelet concentrates after cardiac operations. A scanning electron microscope study of platelet aggregation on extracellular matrix
18. Aprotinin improves hemostasis after cardiopulmonary bypass better than single-donor platelet concentrate
19. Does the platelet-activated clotting test (HemoSTATUS) predict blood loss and platelet dysfunction associated with cardiopulmonary bypass?
20. Comparative evaluation of platelet function assays during cardiopulmonary bypass
21. Evaluation of a new point-of-care test that measures PAF-mediated acceleration of coagulation in cardiac surgical patients
22. Evaluation of the Ultegra®, point-of-care platelet function instrument during cardiac surgery
23. Abciximab in primal coronary angioplasty for acute myocardial infarction improves short- and medium-term outcomes
24. Abciximab reduces mortality in diabetics following percutaneous coronary intervention
25. Effect of clopidogrel treatment on ADP-induced phospholylations in rat platelets
26. The antiaggregating and antithrombotic activity, of clopidogrel is potentiated by aspirin in several experimental models in the rabbit
27. Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass
28. The platelet function defect of cardiopulmonary bypass
29. High-dose heparin suppresses platelet alpha granule secretion
30. Plasmin effect on platelet glycoprotein Ib-von Willebrand factor interactions
31. Plasmin-induced redistribution of platelet glycoprotein Ib
32. Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro
33. Reduction of heparin binding to and inhibition of platelets by aprotinin
34. Inhibition of platelet function by heparin. An etiologic factor in postbypass hemorrhage
35. Thromboelastography in liver transplantation
36. Intraoperative coagulation changes in children undergoing liver transplantation
37. Predicting and treating coagulopathies after cardiopulmonary bypass in children
38. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery
39. Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients
40. Monitoring platelet glycoprotein IIb/IIIa-fibrin interaction with tissue factoro-activated thromboelastography
41. Sonoclot analysis
42. Comparison of thromboelastograph and Sonoclot coagulation analyzer for assessing coagulation status during orthotopic liver transplantation
43. Evaluation of the in vitro detection of the hypercoagulable state using the thrombin generation test and plasma clot impedance test
44. Near-site monitoring of the antiplatelet drug abciximab using the Hemodyne analyzer and modified thrombelastograph
45. A method for the quantitative assessment of platelet-induced clot retraction and clot strength in fresh and stored platelets
46. Measurement of platelet force: The Hemodyne hemostasis analyzer
47. Masking of heparin activity in the activated coagulation time (ACT) by platelet procoagulant activity
48. Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: A randomised controlled trial
49. Rapid platelet-function assay: An automated and quantitative cartridge-based method
50. Rapid and simple platelet function assay to assess glycoprotein IIb/IIIa receptor blockade
51. Antithrombotic effect of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor in an experimental animal model
52. Standardization of the PFA-100(R) platelet function test in 105 mmol/1 buffered citrate: Effect of gender, smoking, and oral contraceptives
53. Description of an in vitro platelet function analyzer - PFA- 100
54. PFA-100 system: A new method for assessment of platelet dysfunction
55. Are in-vitro platelet function tests useful in predicting blood loss following open heart surgery?
56. Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: A 24- institution study
57. Evaluation of coagulation during cardiopulmonary bypass with a heparinase-modified thromboelastographic assay
58. The effect of an intraoperative treatment algorithm on physicians' transfusion practice in cardiac surgery
59. Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation
60. Optimal management of bleeding and transfusion in patients undergoing cardiac surgery
61. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery
62. Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass